Clinical Neuroradiology

, Volume 25, Issue 2, pp 151–159 | Cite as

Evaluation of Oral Anticoagulant-Associated Intracranial Parenchymal Hematomas Using CT Findings

Original Article
First Online:
Received:
Accepted:

Abstract

Purpose

Intracranial hemorrhage (ICH) is one of the most serious and lethal complications of anticoagulants with a reported incidence of 5–18.5 %. Computed tomographic (CT) findings, should be carefully studied because early diagnosis and treatment of oral anticoagulant use-associated hematomas are vitally important. In the present study, CT findings of intraparenchymal hematomas associated with anticoagulant and antihypertensive use are presented.

Methods

This study included 45 patients (25 men, 20 women) under anticoagulant (21 patients) or antihypertensive (24 patients) treatment who had brain CT examinations due to complaints and findings suggesting cerebrovascular disease during July 2010–October 2013 period. CT examinations were performed to determine hematoma volumes and presence of swirl sign, hematocrit effect, mid-line shift effect, and intraventricular extension.

Results

The patients were 40–89 years of age. In four cases, a total of 51 intraparenchymal hematomas (42 cerebral, 7 cerebellar and 2 brain stem) were detected in multiple foci. Hematoma volumes varied from 0.09 to 284.00 ml. Swirl sign was observed in 87.5 and 63.0 % of OAC-associated ICHs and non-OAC-associated ICHs, respectively. In addition, hematocrit effect was observed in 41.6 % of OAC-associated and in 3.7 % of non-OAC-associated ICHs. Volume increases were observed in all 19 hematomas where swirl sign was detected, and follow-up CT scanning was conducted. Mortality of OAC-associated ICHs was correlated with initial volumes of hematoma, mid-line shift amount, and intraventricular extension.

Conclusions

Detection of hematocrit effect by CT scanning of intracranial hematomas should be cautionary in oral anticoagulant use, while detection of swirl sign should be suggestive of active hemorrhage.

Keywords

Computed tomography Hematocrit effect Intracranial hemorrhage Oral anticoagulant Swirl sign 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

There is no additional contribution outside the article authors.

Conflict of Interest

The authors declared no conflicts of interest.

References

  1. 1.
    Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage: facts and hypotheses. Stroke. 1995;26:1471–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Huhtakangas J, Tetri S, Juvela S, Saloheimo P, Bode MK, Hillbom M. Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study. Stroke. 2011;42:2431–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Pfleger MJ, Hardee EP, Contant CF Jr, Hayman LA. Sensitivity and specificity of fluid-blood levels for coagulopathy in acute intracerebral hematomas. AJNR Am J Neuroradiol. 1994;15:217–23.PubMedGoogle Scholar
  4. 4.
    Nizar A, Al-Nakshabandi NA. The swirl sign. Radiology. 2001;218:433.CrossRefGoogle Scholar
  5. 5.
    Moussouttas M, Malhotra R, Fernandez L, Maltenfort M, Holowecki M, Delgado J, Lawson N, Badjatia N. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. Neurocrit Care. 2010;12:24–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Cervera A, Amaro S, Chamorro A. Oral anticoagulant-associated intracerebral hemorrhage. J Neurol. 2012;259:212–24.PubMedCrossRefGoogle Scholar
  7. 7.
    Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I. Anticoagulant treatment as a risk factor for primary intracerebral hemorrhage. J Neurol Neurosurg Psychiatry. 1992;55:1121–4.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Flaherty ML, Haverbusch M, Sekar P, Kissela BM, Kleindorfer D, Moomaw CJ, Broderick JP, Woo D. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care. 2006;5:197–201.PubMedCrossRefGoogle Scholar
  9. 9.
    Fewel ME, Thompson BG Jr, Hoff JT. Spontaneous intracerebral hemorrhage: a review. Neurosurg Focus. 2003;15(4):E1.Google Scholar
  10. 10.
    Flaherty ML. Anticoagulant-associated intracerebral hemorrhage. Semin Neurol. 2010;30:565–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Parizel PM, Makkat S, Van Miert E, Van Goethem JW, van den Hauwe L, De Schepper AM. Intracranial hemorrhage: principles of CT and MRI interpretation. Eur Radiol. 2001;11:1770–83.PubMedCrossRefGoogle Scholar
  12. 12.
    Swensen SJ, McLeod RA, Stephens DH. CT of extracranial hemorrhage and hematomas. AJR Am J Roentgenol. 1984;143:907–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Zimmerman RA, Bilanuk IT. Computed tomographic staging of traumatic epidural bleeding. Radiology. 1982;144:809–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Selariu E, Zia E, Brizzi M, Abul-Kasim K. Swirl sign in intracerebral hemorrhage: definition, prevalence, reliability and prognostic value. BMC Neurol. 2012;12:109.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Thompson AL, Kosior JC, Gladstone DJ, Hopyan JJ, Symons SP, Romero F, Dzialowski I, Roy J, Demchuk AM, Aviv RI; PREDICTS/Sunnybrook ICH CTA Study Group. Defining the CT angiography ‘Spot Sign’ in primary intracerebral hemorrhage. Can J Neurol Sci. 2009 Jul;36:456–61.PubMedCrossRefGoogle Scholar
  16. 16.
    Brouwers HB, Falcone GJ, McNamara KA, Ayres AM, Oleinik A, Schwab K, Romero JM, Viswanathan A, Greenberg SM, Rosand J, Goldstein JN. CTA Spot Sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care. 2012 Dec;17:421–8. doi:10.1007/s12028-012-9765-2.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Mauriño J, Saposnik G, Lepera S, Rey RC, Sica RE. Multiple simultaneous intracerebral hemorrhages: clinical features and outcome. Arch Neurol. 2001;58:629–32.PubMedCrossRefGoogle Scholar
  18. 18.
    Tejero MA, Guerrero-Peral AL, Iglesias F, Gutiérrez-Martín F, Martín-Polo J, Sánchez-Barranco F, Laherrán E, Martín-Serradilla JI. Multiple spontaneous cerebral hemorrhages. Description of a series and review of the literature. Rev Neurol. 2009;48:346–8.PubMedGoogle Scholar
  19. 19.
    Kiphuth IC, Huttner HB, Breuer L, Schwab S, Köhrmann M. Sonographic monitoring of midline shift predicts outcome after intracerebral hemorrhage. Cerebrovasc Dis. 2012;34:297–304.PubMedCrossRefGoogle Scholar
  20. 20.
    Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen E, Hillbom M. Regular aspirin use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006;37:129–33.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Radiology, Medical SchoolGaziosmanpaşa UniversityTokatTurkey
  2. 2.Department of RadiologyZile State HospitalTokatTurkey
  3. 3.Department of Radiology, Medical SchoolOsmangazi UniversityEskişehirTurkey

Personalised recommendations